Corporate leaders are under pressure to protect margins and unlock capital for growth, and many are turning to federal and ...
SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and ...
Full-year 2025 revenue increased by $2.5 million to $59.2 million compared to $56.7 million for the full-year of 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results